AMAG Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference Lazard Capital Markets 9th Annual Healthcare Conference Business Wire LEXINGTON, Mass. -- November 07, 2012 AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Frank Thomas, AMAG’s Chief Operating Officer, will present a company overview and business update at the Lazard Capital Markets 9^th Annual Healthcare Conference on Tuesday, November 13, 2012 at 8:00 am ET in New York, NY. A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until December 13, 2012. About AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit www.amagpharma.com. Contact: AMAG Pharmaceuticals, Inc. Amy Sullivan, 617-498-3303
AMAG Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.